Key result
Echo and CMR drive restrictive cardiomyopathy diagnosis, with CMR tissue characterization pinpointing specific subtypes.
Why the study?
Restrictive cardiomyopathy is rare and challenging to diagnose, requiring evaluation of the role of noninvasive cardiac imaging modalities in diagnosis and treatment.
Systematic Review
Noninvasive imaging, particularly echocardiography and CMR, is essential for diagnosing restrictive cardiomyopathies and differentiating them from constrictive pericarditis to guide appropriate management.
Supports first-line echocardiography and CMR for restrictive cardiomyopathy diagnosis; extends systematic evidence on CMR's subtype differentiation via tissue characterization.
Restrictive cardiomyopathy (RCM) is the least common among cardiomyopathies. It can be idiopathic, familial, or secondary to systematic disorders. Marked increase in left and/or right ventricular filling pressures causes symptoms and signs of congestive heart failure. Electrocardiographic findings are nonspecific and include atrioventricular conduction and QRS complex abnormalities and supraventricular and ventricular arrhythmias. Echocardiography and cardiac magnetic resonance (CMR) play a major role in diagnosis. Echocardiography reveals normal or hypertrophied ventricles, preserved systolic function, marked biatrial enlargement, and impaired diastolic function, often with restrictive filling pattern. CMR offering a higher spatial resolution than echocardiography can provide detailed information about anatomic structures, perfusion, ventricular function, and tissue characterization. CMR with late gadolinium enhancement (LGE) and novel approaches (myocardial mapping) can direct the diagnosis to specific subtypes of RCM, depending on the pattern of scar formation. When noninvasive studies have failed, endomyocardial biopsy is required. Differentiation between RCM and constrictive pericarditis (CP), nowadays by echocardiography, is important since both present as heart failure with normal-sized ventricles and preserved ejection fraction but CP can be treated by means of anti-inflammatory and surgical treatment, while the treatment options of RCM are dictated by the underlying condition. Prognosis is generally poor despite optimal medical treatment.
No takes yet. Share an insight, caveat, or question.
Rammos et al. (2017) conducted a systematic review in Restrictive cardiomyopathy. Noninvasive cardiac imaging modalities (Echocardiography and CMR) was evaluated. Echocardiography and cardiac magnetic resonance play a major role in the diagnosis of restrictive cardiomyopathy, with CMR offering detailed tissue characterization to identify specific subtypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: